Even before the official start of this year’s McKesson ideaShare conference, the Gaylord Palms Resort and Convention Center was buzzing with attendees eager to take advantage of the robust lineup of continuing education courses held on Sunday and Monday.
This year’s McKesson ideaShare 2014 kicked off with a bang as thousands of community pharmacy leaders flocked to Orlando, Fla., to participate in the annual event and seize the opportunities to grow in today’s changing healthcare landscape.
Families this summer will spend slightly more on back-to-school items than they did in 2013. According to NRF’s 2014 Back-to-School Survey conducted by Prosper Insights & Analytics, the average family with children in grades K-12 will spend $669.28 on apparel, shoes, supplies and electronics, up 5% from $634.78 in 2013.
The National Retail Federation is supporting the Marketplace and Internet Tax Freedom Act. The legislation was introduced by Senators Michael Enzi, Richard Durbin, Lamar Alexander, Heidi Heitkamp, Susan Collins and Mark Pryor.
HelpAround on Wednesday launched a mobile platform for people with diabetes — and their friends, family and caregivers — that reveals fellow ‘diabetes helpers’ from the crowd, helping people resolve sudden health crises, such as getting caught without essential over-the-counter blood glucose test strips.
Hamacher Resource Group on Monday announced that Dave Wendland, Hamacher VP, will present "Rx-to-OTC: Getting It Right at Retail," an educational videocast for retailers sponsored by the Global Market Development Center on Thursday, July 17.
The National Association of Chain Drug Stores on Tuesday put forward pharmacy-specific solutions as the Senate Finance Committee conducted a hearing on “Chronic Illness: Addressing Patients’ Unmet Needs.”
Pure Encapsulations recently launched PureBiOme, a line of probiotics using proprietary PureBiOme freeze-drying technology, which enables probiotics to maintain potency when combined with active ingredients for the first time.
Although the pace of approvals for new orphan drugs — medicines that treat relatively rare conditions — have increased in the United States and Europe in recent years, patients are facing growing challenges accessing those drugs, a newly completed study released last week by the Tufts Center for the Study of Drug Development at Tufts University has concluded.